Texas Biomedical Research Institute
Texas Biomedical Research Institute (Texas Biomed), located in San Antonio, Texas, is an independent biomedical research institution, specializing in genetics and in virology and immunology. Texas Biomed is funded by government and corporate grants and contracts, and donations from the public. Founded in 1941 by Tom Slick as the Foundation of Applied Research, Texas Biomed became the Southwest Foundation for Research and Education in 1952, Southwest Foundation for Biomedical Research (SFBR) in 1982, and Texas Biomedical Research Institute on February 1, 2011. Located on a 200-acre (0.81 km) campus on the northwest side of San Antonio, Texas Biomed employs over 75 doctoral level biomedical scientists, including 28 principal investigators and 400 staff members. Focused on basic biomedical research, the Institute is divided into the Department of Genetics and the Department of Virology & Immunology. The Southwest National Primate Research Center, a part of Texas Biomed, is an international resource that provides specialized facilities and expertise in research with nonhuman primates to investigators from around the US and other countries. It maintains 4,000 nonhuman primates.
Four genes indentified that influence levels of 'bad' cholesterol
Scientists at the Texas Biomedical Research Institute in San Antonio have identified four genes in baboons that influence levels of "bad" cholesterol. This discovery could lead to the development of new drugs to reduce the ...
Medical research
May 15, 2013 |
4.5 / 5 (2) |
0
|
New drug stimulates immune system to kill infected cells in animal model of hepatitis B infection
A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of ...
Diseases, Conditions, Syndromes
Apr 26, 2013 |
4.5 / 5 (2) |
0
Naturally occurring substance proves effective against deadly skin cancer in laboratory tests
For the first time, scientists have demonstrated the mechanism of action of gossypin, a naturally-occurring substance found in fruits and vegetables, as a treatment for melanoma, which causes the majority of deaths from skin ...
Cancer
Apr 10, 2013 |
5 / 5 (1) |
0
Currently approved drugs found effective in laboratory mice against bioterror threats
In the most extensive screen of its kind, Texas Biomed scientists in San Antonio have demonstrated the feasibility of repurposing already-approved drugs for use against highly pathogenic bacteria and viruses. The pathogens ...
Medical research
Apr 09, 2013 |
not rated yet |
0
|
Highly lethal Ebola virus has diagnostic Achilles' heel for biothreat detection, scientists say
By screening a library of a billion llama antibodies on live Ebola viruses in the Texas Biomedical Research Institute's highest biocontainment laboratory, scientists in San Antonio have identified a potential weakness in ...
Medical research
Apr 05, 2013 |
4.3 / 5 (4) |
0
|
Gum disease found to worsen infection in animal model of AIDS
Texas Biomed scientists in San Antonio have found that moderate gum disease in an animal model exposed to an AIDS- like virus had more viral variants causing infection and greater inflammation. Both of these features have ...
HIV & AIDS
Jan 31, 2013 |
not rated yet |
0
Stem cells found to heal damaged artery in lab study
Scientists at the Texas Biomedical Research Institute have for the first time demonstrated that baboon embryonic stem cells can be programmed to completely restore a severely damaged artery. These early results show promise ...
Medical research
Jan 10, 2013 |
5 / 5 (2) |
0
|
Texas Biomed files patent for a novel HIV vaccine strategy
The Texas Biomedical Research Institute in San Antonio has applied for a patent for a genetically-engineered vaccine strategy to prevent HIV infection that targets the outer layers of body structures that are the first sites ...
HIV & AIDS
Nov 19, 2012 |
5 / 5 (1) |
0
Antibody prevents hepatitis C in animal model
A monoclonal antibody developed by MassBiologics of the University of Massachusetts Medical School (UMMS) and tested in an animal model at the Texas Biomedical Research Institute, prevents infection by the hepatitis C virus ...
Diseases, Conditions, Syndromes
Aug 30, 2012 |
5 / 5 (1) |
0
|
New animal model may lead to treatments for common liver disease
Scientists at Texas Biomed have developed the laboratory opossum as a new animal model to study the most common liver disease in the nation afflicting up to 15 million Americans and for which there is no cure.
Diseases, Conditions, Syndromes
Jul 03, 2012 |
not rated yet |
0